NCT06073483

Brief Summary

This clinical study was a prospective, single-center, single-arm exploratory study. Subjects who meet the inclusion criteria will be enrolled in this study, where surgeons will perform 5G remote gastrectomy on subjects using the Toumai endoscopic surgery system, and explore and evaluate the safety and efficacy of this clinical application.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable gastric-cancer

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable gastric-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 7, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 10, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

October 15, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2024

Completed
Last Updated

October 10, 2023

Status Verified

October 1, 2023

Enrollment Period

7 months

First QC Date

September 7, 2023

Last Update Submit

October 5, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • The rate of intraoperative complications

    Intraoperative complications, including organ injury and vascular injury, were evaluated using the Satava grading system to determine whether the occurrence of complications was related to the study instrument or surgery

    The day of surgery

  • The rate of postoperative complications

    Postoperative complications, including postoperative bleeding, fever, and incisional infection, were evaluated using the Clavien-Dindo grading system to determine whether the occurrence of complications was related to the study instrument or surgery.

    Postoperative 30 days

Secondary Outcomes (6)

  • Intraoperative system failure rate

    The day of surgery

  • Surgical completion rate

    The day of surgery

  • Intraoperative blood loss

    The day of surgery

  • Operation time

    The day of surgery

  • Preoperative device assembly time

    The day of surgery

  • +1 more secondary outcomes

Study Arms (1)

5G remote gastrectomy

EXPERIMENTAL
Device: Toumai Endoscopic surgery System

Interventions

5G remote gastrectomy on subjects using the Toumai endoscopic surgery system

5G remote gastrectomy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old ≤ actual age ≤80 years old.
  • Patients requiring gastrointestinal endoscopic surgery.
  • Willing to cooperate with and complete the study follow-up and related examinations.
  • Voluntarily participate in the study and sign the informed consent in person.

You may not qualify if:

  • Have serious cardiovascular or circulatory disease and cannot tolerate surgery.
  • Participated in other clinical trials within the last 3 months.
  • Inability to understand trial requirements, or inability to complete the study follow-up plan.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of General Surgery

Shijiazhuang, Hebei, 050011, China

RECRUITING

MeSH Terms

Conditions

Stomach Neoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 7, 2023

First Posted

October 10, 2023

Study Start

October 15, 2023

Primary Completion

May 15, 2024

Study Completion

June 15, 2024

Last Updated

October 10, 2023

Record last verified: 2023-10

Locations